| pubmed-article:8093269 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8093269 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8093269 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:8093269 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
| pubmed-article:8093269 | lifeskim:mentions | umls-concept:C0807093 | lld:lifeskim |
| pubmed-article:8093269 | lifeskim:mentions | umls-concept:C1441055 | lld:lifeskim |
| pubmed-article:8093269 | pubmed:issue | 8836 | lld:pubmed |
| pubmed-article:8093269 | pubmed:dateCreated | 1993-1-27 | lld:pubmed |
| pubmed-article:8093269 | pubmed:abstractText | We describe three patients with known or suspected small-cell lung cancer (SCLC), paraneoplastic neurological syndromes, and antineuronal antibodies who had unusually benign clinical courses. One patient survived 8 years free of disease and was positive for the anti-Hu antibody. A second patient survived 6 years after spontaneous tumour regression and had an atypical antineuronal antibody. A third patient with both the anti-Hu and atypical antineuronal antibody had spontaneous regression of a lung mass. All three patients had a subacute sensory neuropathy. Since paraneoplastic antineuronal antibodies also bind to tumour cells, these cases suggest that some (paraneoplastic) neurological syndromes without identifiable tumour may result from immune-mediated eradication of tumour cells. | lld:pubmed |
| pubmed-article:8093269 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8093269 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8093269 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8093269 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8093269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8093269 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8093269 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8093269 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:8093269 | pubmed:author | pubmed-author:DeAngelisL... | lld:pubmed |
| pubmed-article:8093269 | pubmed:author | pubmed-author:DarnellR BRB | lld:pubmed |
| pubmed-article:8093269 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8093269 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:8093269 | pubmed:volume | 341 | lld:pubmed |
| pubmed-article:8093269 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8093269 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8093269 | pubmed:pagination | 21-2 | lld:pubmed |
| pubmed-article:8093269 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:meshHeading | pubmed-meshheading:8093269-... | lld:pubmed |
| pubmed-article:8093269 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8093269 | pubmed:articleTitle | Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. | lld:pubmed |
| pubmed-article:8093269 | pubmed:affiliation | Department of Neurology, Memorial Sloan Kettering Cancer Center, New York. | lld:pubmed |
| pubmed-article:8093269 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8093269 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8093269 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8093269 | lld:pubmed |
